Nagoya Ekisaikai Hospital

Nagoya 454-8502

1 studies enrolling now · 3 studies all time

What they study most

Amyloid, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cognitive Dysfunction, Lewy Body Disease, Synucleinopathies

Studies at this site

• A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) — Recruiting now
• A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Running, not enrolling
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed